AVR vs. FNA, BFLY, EYE, ESTA, EMBC, BBNX, BVS, AXGN, CBLL, and AVNS
Should you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include Paragon 28 (FNA), Butterfly Network (BFLY), National Vision (EYE), Establishment Labs (ESTA), Embecta (EMBC), Beta Bionics (BBNX), Bioventus (BVS), AxoGen (AXGN), CeriBell (CBLL), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry.
Anteris Technologies Global vs.
Paragon 28 (NYSE:FNA) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, community ranking, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.
Anteris Technologies Global has lower revenue, but higher earnings than Paragon 28.
Anteris Technologies Global has a net margin of 0.00% compared to Paragon 28's net margin of -25.31%. Anteris Technologies Global's return on equity of 0.00% beat Paragon 28's return on equity.
Paragon 28 currently has a consensus price target of $14.60, suggesting a potential upside of 12.18%. Anteris Technologies Global has a consensus price target of $16.50, suggesting a potential upside of 100.00%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Paragon 28.
In the previous week, Anteris Technologies Global had 1 more articles in the media than Paragon 28. MarketBeat recorded 1 mentions for Anteris Technologies Global and 0 mentions for Paragon 28. Paragon 28's average media sentiment score of 0.00 equaled Anteris Technologies Global'saverage media sentiment score.
Paragon 28 received 31 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. However, 100.00% of users gave Anteris Technologies Global an outperform vote while only 76.09% of users gave Paragon 28 an outperform vote.
63.6% of Paragon 28 shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Anteris Technologies Global beats Paragon 28 on 8 of the 12 factors compared between the two stocks.
Get Anteris Technologies Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Anteris Technologies Global Competitors List
Related Companies and Tools
This page (NASDAQ:AVR) was last updated on 2/22/2025 by MarketBeat.com Staff
